DuPont takes the plunge into life sciences

Article Abstract:

Chemicals giant DuPont intends to gradually become a life sciences corporation, exemplified by one of its newest innovations addressing waste, a biodegradable PET plastic made from corn sugar at DuPont Australia. It will focus on plant-based rather than petrochemicals-based production, and thus has recently acquired full control of the world's largest seed company.

Plastics Material and Resin Manufacturing, Plastics materials and resins, Polyethylene Terephthalate Plastics, Statistical Data Included, Innovations, Plastics industry, Chemical industry, E.I. du Pont de Nemours and Co., Company Profile, Polyethylene terephthalate, DuPont Australia

---

Tax - double-dip relief

Article Abstract:

Suggestions are offered to Australians outside the workforce for availing relief from capital gains tax through contributions to superannuation funds.

Public Finance Activities, Financial management, Management dynamics, Other Financial Vehicles, Pension, health, and welfare funds, Pension Funds & Benefit Plans, Pension Funds, Investors, not elsewhere classified, Capital Gains Taxes, Tax Shelter Investment Svcs NEC, Methods, Usage, Finance, Tax planning, Company business management, Capital gains tax, Tax shelters, Company financing

---

A bio-info bonding

Article Abstract:

IBM has selected a partner for its new life-sciences division. The global strategic alliance will be with Proteome Systems.

Computer and Office Equipment, Office & Computing Machines, Office equipment, Office equipment and supplies industry, Office equipment industry, International Business Machines Corp., IBM, Proteome Systems Ltd.

Similar abstracts:

• Abstracts: If you can't beat them, join them in strategic alliance. The new alchemy. Dreaming of vertical integration
• Abstracts: End of the line for prince of annuities. APN's pale blue sky. APN's Kiwi catch
• Abstracts: Secondary markets stir. Picking shock-proof stocks for scary times. The future is ours--maybe
• Abstracts: Women at the top. Patchy but still promising; the latest corporate results have been compromised by a few dismal performers
• Abstracts: Cancer stocks grow. Medicare cuts an artery. The next code crackers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.